CPT code 85291: Factor XIII screen, solubility screening2026 Medicare lab fee · Clinical Laboratory Fee Schedule
A plasma-based screen for severe factor XIII deficiency, used when delayed bleeding or poor clot stability suggests impaired fibrin stabilization.
Medicare pays $9.11 for 85291 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$9.11
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 85291 covers
This coagulation screen assesses whether a formed fibrin clot remains stable under solubilizing conditions, helping identify severe factor XIII deficiency. It is considered when delayed bleeding or poor clot stability raises concern, including cases in which routine coagulation tests do not explain the bleeding. A coagulation laboratory typically performs the test on plasma during evaluation of an inherited or acquired bleeding disorder.
Report 85291 for the factor XIII solubility screen, rather than for a different factor XIII test such as 85290. Medicare pays 85291 only through the CLFS. The 2026 national CLFS amount is $9.11, unchanged since 2020. One national amount applies across states and localities, with no geographic adjustment or office-versus-facility difference. Medicare payment for this test is through the CLFS, not the physician fee schedule.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 85291
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 85291. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 85291 with status X (excluded by statute), so the test itself is paid only from the CLFS.
85291 on the lab fee schedule since 2020
85291 · CLFS 2026 Q4 (current)
$9.11
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
85291 compared with similar tests
- 85290Factor XIII testFibrin-stabilizing factor$16.34
- 85291 is the factor XIII solubility screen; 85290 identifies a different factor XIII test.
- 85240Factor VIIIOne-stage activity$17.90
- 85240 tests factor VIII, not factor XIII. Select it when factor VIII testing is performed.
- 85280Factor XIIHageman factor activity$19.35
- 85280 tests factor XII, not factor XIII. Select it when factor XII testing is performed.
85291 billing questions
When should 85291 be used instead of 85290?
Use 85291 for the factor XIII solubility screen. Code 85290 identifies a different factor XIII test.
What clinical findings can prompt this screen?
Delayed bleeding or poor clot stability may raise concern for factor XIII deficiency, including when routine coagulation results do not explain the bleeding.
What specimen is tested?
The test is performed on plasma to assess the stability of a formed fibrin clot.
Does Medicare pay 85291 through the CLFS?
Yes. Medicare pays it through the CLFS using one national amount regardless of locality or office-versus-facility setting.
Is there a separate physician interpretation payment?
No. Medicare payment for 85291 is through the CLFS, not the physician fee schedule.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 85291 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist